Oak Hill, which has operations in the UK and US, will focus on developing therapies for extremely preterm infants and patients suffering from rare autoimmune diseases. A pipeline with potential Of the six acquired programmes in Oak Hill’s pipeline, two are clinical-stage candidates, and both ar...
根据一项2期临床试验公布的结果:CAR-NK细胞疗法TAK-007,在复发/难治性B细胞非霍奇金淋巴瘤患者中,表现出良好的早期疗效和安全性。该研究的蕞新数据已在2024年美国血液学会(ASH)年会上发布。TAK-007是由美国MD安德森癌症中心开发的一款CD19靶向CAR-NK细胞疗法,日本武田制药(Takeda)获得了TAK-007的研发和销售权,并...
27,684 febrile illnesses were reported, leading to detection of 1,007 RT-PCR confirmed dengue cases; of which, 188 required hospitalization (placebo group, n=142; TAK-003 group, n=46). Cumulative vaccine efficacy (VE; 95% CI) across all countries from first dose until 4.5 years post ...